EricMMcDadeDO

Neurology • Saint Louis, MO

Neurodegenerative, Dementia & Geriatrics

Professor of Neurology Washington University School of Medicine. Co-Director Dominantly Inherited Alzheimer Network Trials Unit.

Join to view full profile

Dr. McDade is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McDade's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-362-1408

Fax+1 314-286-1985

Summary

Dr. Eric McDade is a neurologist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital. He received his medical degree from Chicago College of Osteopathic Medicine at Midwestern University and has been in practice 12 years. He specializes in neurodegenerative and dementia & geriatrics and is experienced in alzheimer's disease and aphasia. He has more than 100 publications and over 500 citings.

Education & Training

Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2008 - 2010
University of MarylandResidency, Neurology, 2005 - 2008
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2004 - 2005
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2004

Certifications & Licensure

IL State License 2021 - 2026
MO State License 2016 - 2026
PA State License 2010 - 2016
MN State License 2008 - 2010
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Dominantly Inherited Alzheimer Network (DIAN)
RECRUITING

Publications & Presentations

PubMed

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, ...
Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford
The Lancet. Neurology. 2025-04-01
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.
David M Cash, Katy E Morgan, Antoinette O'Connor, Thomas D Veale, Ian B Malone
The Journal of Prevention of Alzheimer's Disease. 2025-03-20
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last ...
Guoqiao Wang, Tianle Chen, John O'Gorman, Yan Li, Caiyan Li
Medrxiv. 2025-02-21

Other

Stop Alzheimer’s Before It Starts
Eric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2011-10-05
Stop Alzheimer’s Before It Starts
Eric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2013-02-06

Press Mentions

Small Study Hints Anti-Amyloid Therapy May Keep Alzheimer’s Symptoms at Bay in Certain PatientsMarch 21st, 2025
Groundbreaking Alzheimer’s Prevention Trial Starts for Young AdultsFebruary 4th, 2025
International Alzheimer’s Prevention Trial in Young Adults BeginsFebruary 4th, 2025
Join now to see all

Grant Support

Multidisciplinary Training in Alzheimer and Related DementiasWASHINGTON UNIVERSITY2018–2029
DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
K23National Institution on Aging2015–2020